SlideShare a Scribd company logo
1 of 49
Download to read offline
GI Disorders in Women:
       Clinical Pearls

Amy S. Oxentenko, MD, FACP, FACG
  Division of Gastroenterology and Hepatology
           Mayo Clinic, Rochester, MN
                   March, 2012
Disclosure of Financial Relationships

Amy S. Oxentenko, MD, FACP, FACG

   Has no relationships with any entity
   producing, marketing, re-selling, or
distributing health care goods or services
   consumed by, or used on, patients.
Case #1
A 32 y/o female presents for evaluation of “diarrhea” and
abdominal pain that she has had for 5 years. She gets lower
abdominal pain and bloating 1-2 times per week. On those
days, she reports 3-5 loose stools, predominantly in the
morning or after meals. Stools are non-bloody, non-greasy
and never nocturnal. Stooling brings relief of her pain. She
denies weight loss. PMH is unremarkable. She takes no
meds. She has no family hx of GI problems. Exam is normal.

Which of the following is the next best step?


        A.   No further tests; reassurance
        B.   CBC & IgA tissue transglutaminase
        C.   Stool cultures
        D.   EGD w/ small bowel biopsies
        E.   Colonoscopy w/ random biopsies
A 32 y/o female presents for evaluation of “diarrhea” and
abdominal pain that she has had for 5 years. She gets lower
abdominal pain and bloating 1-2 times per week. On those
days, she reports 3-5 loose stools, predominantly in the
morning or after meals. Stools are non-bloody, non-greasy
and never nocturnal. Stooling brings relief of her pain. She
denies weight loss. PMH is unremarkable. She takes no
meds. She has no family hx of GI problems. Exam is normal.

Which of the following is the next best step?


        A.   No further tests; reassurance
        B.   CBC & IgA tissue transglutaminase
        C.   Stool cultures
        D.   EGD w/ small bowel biopsies
        E.   Colonoscopy w/ random biopsies
Be Comfortable Diagnosing IBS




        Spiller RC, et al. Am J Gastroenterol 2010:105;775-75.
        Brandt LJ, et al. Am J Gastroenterol 2009;104:S1-35.
Irritable Bowel Syndrome
                Hard and lumpy




                Loose or watery
Clinical Pearl
  Diarrhea-predominant irritable bowel
  syndrome is a diagnosis that can be
  made with little exclusionary testing
required, other than a CBC and IgA tTG,
   in the absence of alarm symptoms.
Case #2
A 38 y/o female presents to the ER with recurrent abdominal pain,
nausea and bilious vomiting. Six months ago, she had a Roux-en-Y
gastric bypass for obesity. She has had 3 episodes in 1 month.
Pain is crampy, periumbilical, and crescendos over 1-2 hours and
is relieved after vomiting undigested food and bilious fluid. During
the last 2 episodes, ER eval with labs (CBC, liver biochemistries),
abdominal radiographs and RUQ ultrasounds were normal. She
takes a MVI w/ iron, thiamine, calcium, vitamin D and B12, but no
other meds. No other PMH. Her gallbladder was not removed w/
the laparoscopic bypass.

Which of the following is the most likely cause of symptoms?

                 A.   Overeating
                 B.   Biliary colic
                 C.   Internal hernia
                 D.   Stenosis of the gastric pouch
                 E.   Medication side effect
A 38 y/o female presents to the ER with recurrent abdominal pain,
nausea and bilious vomiting. Six months ago, she had a Roux-en-Y
gastric bypass for obesity. She has had 3 episodes in 1 month.
Pain is crampy, periumbilical, and crescendos over 1-2 hours and
is relieved after vomiting undigested food and bilious fluid. During
the last 2 episodes, ER eval with labs (CBC, liver biochemistries),
abdominal radiographs and RUQ ultrasounds were normal. She
takes a MVI w/ iron, thiamine, calcium, vitamin D and B12, but no
other meds. No other PMH. Her gallbladder was not removed w/
the laparoscopic bypass.

Which of the following is the most likely cause of symptoms?

                 A.   Overeating
                 B.   Biliary colic
                 C.   Internal hernia
                 D.   Stenosis of the gastric pouch
                 E.   Medication side effect
Gastric                 Gastric
 pouch                   remnant


  Bilio-
                         Roux limb
pancreatic
   limb


                         Common
                         channel

             Roux-en-Y
              Bypass
***Lesser                   ***Greater
           malabsorption               malabsorption


Short Roux limb            Long Roux limb
Long common channel        Short common channel
Early Emergent Complications
• Anastomotic leaks
  – Early complication
  – Only feature may be
    unexplained tachycardia
Early Emergent Complications
• Anastomotic leaks
  – Early complication
  – Only feature may be
    unexplained tachycardia
• Internal hernias
  –   Occurs early or late
  –   Nausea, vomiting (? bilious)
  –   Increased w/ laparoscopy;
      only occurs with bypass
• Both need surgery!!!

                      Klein S, et al. Gastroenterology 2002;123:882-932.
Other Common Complications
• Marginal ulceration
  – May cause bleeding or
    stricture at G-J site
  – May create stomal stenosis
  – ? NSAIDs, ? smoking
• Bleeding
  – Can occur at any
    anastomotic site
  – Think of remnant stomach
    and duodenum
  – After routine EGD, may need
    GI expertise to evaluate
Other Common Complications
• Biliary stone disease
  – ERCP scope 124 cm; cannot
    reach papilla in RYGB pts
       • Typical Roux limb 100-150 cm
  – Approach dependent on clinical
    acuity and local expertise
                                        papilla
• Nutritional deficiencies
  –   Iron, B12, Ca++, vitamin D
  –   Folate (give if childbearing)
  –   Thiamine (esp 1st 6 months)
Clinical Pearl

There are many potential structural,
     absorptive and nutritional
complications of bariatric surgery;
  knowledge of the post-bariatric
 anatomy is essential in being able
    to effectively manage these
               patients.
Case #3
34 y/o female referred for “IBS” who is 16 weeks
pregnant. She had diarrhea in teens which resolved in
her 20’s and recurred early in pregnancy. Has 4-6 BM
daily with nocturnal stools. No abdominal pain. Takes
a prenatal MVI, iron and levo-thyroxine. Her pre-
pregnancy BMI = 17, with 5 lb weight gain thus far.
Conceived her baby with IVF. Her TSH is normal.

Which of the following is the next best step?

        A.   Tissue transglutaminase IgA
        B.   Colonoscopy
        C.   Begin scheduled loperamide
        D.   Stool bacterial cultures
        E.   Begin nortriptyline
34 y/o female referred for “IBS” who is 16 weeks
pregnant. She had diarrhea in teens which resolved in
her 20’s and recurred early in pregnancy. Has 4-6 BM
daily with nocturnal stools. No abdominal pain. Takes
a prenatal MVI, iron and levo-thyroxine. Her pre-
pregnancy BMI = 17, with 5 lb weight gain thus far.
Conceived her baby with IVF. Her TSH is normal.

Which of the following is the next best step?

        A.   Tissue transglutaminase IgA
        B.   Colonoscopy
        C.   Begin scheduled loperamide
        D.   Stool bacterial cultures
        E.   Begin nortriptyline
General and GI Manifestations
         of Celiac Disease
         General                    Gastrointestinal
         Short stature              Diarrhea, steatorrhea
         Weight loss*               Flatulence, distension
         Failure to thrive          Abdominal discomfort
         Lethargy                   Anorexia, nausea, vomiting
         Delayed puberty            Constipation**
         Edema                      Angular cheilosis, glossitis


Rubio-Tapia A, Murray JA.                            * 10%+ obese
Curr Opin Gastroenterol 2010; 26:116-22.             ** 20% constipated
Extraintestinal Manifestations:
          Celiac Disease
Category           Examples
Hematologic        Anemia (iron*, B12, folate); functional asplenia (HJ-bodies)
Musculoskeletal    Osteopenia/osteoporosis; osteomalacia; arthropathy
Neurologic         Seizures; peripheral neuropathy; ataxia
Reproductive       Infertility; recurrent miscarriages
Skin               Dermatitis herpetiformis
Other              Enamel defects; abnormal liver biochemistries; vitamin-
                   deficient states, cardiomyopathy, depression/mood
                  •*Prevalence of CD in pts with IDA:
                        •3-9% (no GI sxs)
                        •10-15% (GI sxs)

                     Rubio-Tapia A, Murray JA. Curr Opin Gastroenterol 2010; 26:116-22.
How to Diagnose Celiac Disease
• TTG IgA single best screening test
   – IgA levels not warranted for all
• Small bowel biopsies in:
   –   All with positive serologies
   –   Negative serology but clinical suspicion
   –   Iron deficiency anemia
   –   Other unexplained extraintestinal features
• Treatment: Lifelong, strict gluten-free diet
   – Wheat, barley, rye (oats for 1st year)
Celiac Follow-Up
• Baseline:
   – Dietician, DEXA (latter for adults only)
   – CBC, folate, ferritin, B12, Ca++, zinc, copper, vit
     D, INR, retinol, albumin, ALT, alk phos
• Follow-up visit 3-6 months:
   – Assess clinical sxs, serologies
• Annual visits thereafter:
   – Assess clinical sxs, serologies, dietician
   – Follow-up abnormal labs; DEXA if first abnormal
• Repeat biopsies ONLY for those:
   – Asymptomatic presentations
   – Persistent or recurrent sxs
                                 Leffler D. JAMA
Clinical Pearl
   Celiac disease now commonly
     presents with “atypical” or
 extraintestinal features; heightened
awareness of these features is key to
      thinking of the diagnosis.
Case #4
28 y/o female presents with constipation for 5 years.
Reports one BM every 5-7 days. She has to strain and
has a sense of incomplete evacuation. She has had to
digitalize on occasion to evacuate a stool. No blood.
Had a significant tear with her vaginal delivery 6 years
ago, requiring forceps delivery. No FHx colon cancer.
Weight stable. Exam normal with the exception of
paradoxical contraction of the external anal sphincter.

What is the most likely diagnosis?
           A. Irritable bowel syndrome
           B. Slow-transit constipation
           C. Rectal prolapse
           D. Hirschsprung’s
           E. Pelvic floor dysfunction
28 y/o female presents with constipation for 5 years.
Reports one BM every 5-7 days. She has to strain and
has a sense of incomplete evacuation. She has had to
digitalize on occasion to evacuate a stool. No blood.
Had a significant tear with her vaginal delivery 6 years
ago, requiring forceps delivery. No FHx colon cancer.
Weight stable. Exam normal with the exception of
paradoxical contraction of the external anal sphincter.

What is the most likely diagnosis?
           A. Irritable bowel syndrome
           B. Slow-transit constipation
           C. Rectal prolapse
           D. Hirschsprung’s
           E. Pelvic floor dysfunction
How to Define Constipation?
   • In the past:
        – < 3 stools per week
   • More recent:
        – Effort to defecate
        – Consistency and form
             • Bristol stool form scale
             • Correlates w/ transit
               times


Brandt LJ, et al. Am J Gastroenterol 2005;100:S5-21.
3 Subtypes of Primary
            Constipation
•   Slow-transit constipation
    –   Prolonged transit due to myopathy or
        neuropathy
•   Pelvic floor dysfunction
    –   Also referred to as dyssynergic defecation
    –   Impaired abdominal, rectoanal and pelvic floor
        muscle coordination
•   Constipation-predominant IBS
    –   Pain or discomfort a predominant symptom;
        transit and pelvic function normal
                  Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94.
Alarm Features for
           Constipation?
•   Age > 50 years
•   Short duration symptoms (< 6 months)
•   Family hx colorectal cancer
•   Blood in stools
•   Weight loss

      *** These patients need an evaluation
          which includes colonoscopy ***
Work-Up for Constipation
•   CBC, calcium, TSH, fasting glucose

•   If ≥ 50 or alarm features  colonoscopy

•   If features of pelvic floor dysfunction 
    a) Anorectal manometry/balloon expulsion
    b) Colonic transit study
      •   1) radio-opaque markers, or
      •   2) scintigraphy, or
      •   3) pH capsule
Clinical Features of
  Pelvic Floor Dysfunction
• Risk factors: childbirth, abuse, chronic
  constipation, other pelvic trauma
• Excessive straining, toilet rocking or
  repositioning
• Sense of incomplete evacuation
• Sense of anorectal blockage*
• Digitation for stool evacuation*

             Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94.
Examination Features of
    Pelvic Floor Dysfunction
•   Abnormal perineal descent
•   Abnormal resting and squeeze tone
•   Paradoxical contraction of
    puborectalis or external anal
    sphincter



             Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94.
Pelvic Floor Dysfunction
Normal Rest                    Normal defecation




  Those with pelvic floor dysfunction have paradoxical
  contraction of puborectalis and external sphincter
Management of Pelvic Floor
      Dysfunction
• Refer for biofeedback program
• Significantly improves (for at least 1 year):
  •   Spontaneous BMs
  •   Dyssynergia
  •   Balloon expulsion time
  •   Colonic transit time
• If there is concomitant prolapse, fix pelvic
  floor dysfunction first

          Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94.
          Rao SSC, et al. Am J Gastroenterol 2010;105:890-6.
Clinical Pearl

 Constipation associated with a sense of
anorectal blockage, the need for digitation
    to evacuate stool, and paradoxical
     contraction of the puborectalis is
  suggestive of pelvic floor dysfunction;
    anorectal manometry is indicated.
Case #5
A 58 year old female presents for an evaluation of diarrhea that
has been present for 4 months. She has crampy pain, bloating
and weight loss of 10 pounds. She denies any blood in her
stool, but notes it to be foul smelling and greasy appearing. No
recent medication changes. No travel. She does have a history
of prior cervical cancer 4 years ago, s/p resection,
chemotherapy and radiation. Labs reveal a hemoglobin of 10.4
g/dL, MCV of 102 fL and albumin of 3.1 g/dL. She states that
dairy avoidance has somewhat, but not fully, helped. TTG IgA is
normal. Colonoscopy with ileal inspection is normal.

Which of the following is the next best step?

              A.   CT of the pancreas
              B.   Lactose breath test
              C.   PET scan
              D.   Lactulose breath test
              E.   Flex sig w/ biopsies
A 58 year old female presents for an evaluation of diarrhea that
has been present for 4 months. She has crampy pain, bloating
and weight loss of 10 pounds. She denies any blood in her
stool, but notes it to be foul smelling and greasy appearing. No
recent medication changes. No travel. She does have a history
of prior cervical cancer 4 years ago, s/p resection,
chemotherapy and radiation. Labs reveal a hemoglobin of 10.4
g/dL, MCV of 102 fL and albumin of 3.1 g/dL. She states that
dairy avoidance has somewhat, but not fully, helped. TTG IgA is
normal. Colonoscopy with ileal inspection is normal.

Which of the following is the next best step?

              A.   CT of the pancreas
              B.   Lactose breath test
              C.   PET scan
              D.   Lactulose breath test
              E.   Flex sig w/ biopsies
©2011 MFMER | 3149421-42
Causes of Bacterial Overgrowth
                Small bowel diverticula
Structural
                Small bowel strictures (radiation, IBD, NSAIDs)
                Enterocolonic fistula
                Blind loops, afferent limbs
Surgical
                Ileocecal valve resection
                Chronic pseudoobstruction (Scleroderma)
Dysmotility
                Amyloidosis
                Diabetic neuropathy
                Achlorhydria/atrophy
Diminished
                Gastric resection
Acid            Acid suppression
                Chronic liver or kidney disease
Other
                Chronic pancreatitis
                Immunodeficiencies
                Celiac disease
                Elderly (15% prevalence)
Diagnosis of SIBO
• Small bowel cultures
  – Anaerobic & aerobic; > 105 organisms/mL
  – Jejunum; most taken from duodenum
• Hydrogen breath testing
  –   Lactulose (rise by 20 ppm first 90 min)
  –   Glucose (rise by 12 ppm first 90 min)
  –   2nd criteria = double peak (small bowel, colon)
  –   False (+): rapid transit, recent food
  –   False (-): methane producer (10%), antibiotics
• Empiric Trial of Antibiotics
Breath Testing SIBO
      A                        B                          C




A) Lactulose breath test without SIBO
B) Lactulose breath test w/ SIBO
C) Lactulose breath test w/ SIBO & double-peak pattern


From Dukowicz AC, et al. Gastroenterol Hepatol 2007;3:118-119.
                                                            ©2011 MFMER | 3149421-45
Treatment of SIBO
• Modify underlying risk factor (minority)
  – Diabetes, surgery, etc.
• Nutritional support
  – Correct deficiencies (vit B12, vit D, Ca++)
  – Lactose malabsorption (secondary)
• Antibiotic therapy
  –   Single 7-10 days (46-90% improve for months)
  –   Recurrence 44% at 9 months
  –   Some may need repeat courses (1 week/month)
Treatment for Bacterial Overgrowth
Ciprofloxacin                       250 mg BID
Norfloxacin                         800 mg QD
Metronidazole                       250 mg TID
Trimethoprim-SMX                    1 DS BID
Doxycycline                         100 mg BID
Tetracycline                        250 mg QID
Amoxicillin-clavulanate             500 mg TID
Rifaximin                           800-1200 mg QD

     Quigley EMM, et al. Infect Dis Clin N Am 2010; 24: 943-59.
Clinical Pearl

Small intestinal bacterial overgrowth
  is typically diagnosed with small
 bowel cultures or hydrogen breath
   testing; management includes
correcting nutritional abnormalities
        and antibiotic therapy.

                                 ©2011 MFMER | 3149421-48
Thank you!
oxentenko.amy@mayo.edu

More Related Content

What's hot

[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)Alex J Mitchell
 
Family Physician's Approach to Erectile Dysfunction
Family Physician's Approach to Erectile DysfunctionFamily Physician's Approach to Erectile Dysfunction
Family Physician's Approach to Erectile DysfunctionSiewhong Ho
 
Am 8.40 diaz
Am 8.40 diazAm 8.40 diaz
Am 8.40 diazplmiami
 
Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation Dr. Amit Chougule
 
Many Faces of Hypothyroidism, Dr. Sharda Jain
 Many Faces of Hypothyroidism, Dr. Sharda Jain  Many Faces of Hypothyroidism, Dr. Sharda Jain
Many Faces of Hypothyroidism, Dr. Sharda Jain Lifecare Centre
 
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...Mohand Yaghi
 
Erectile dysfunction in diabetes
Erectile dysfunction in diabetesErectile dysfunction in diabetes
Erectile dysfunction in diabetesPeninsulaEndocrine
 
hypothyrodsim in trisomy 21
hypothyrodsim in trisomy 21hypothyrodsim in trisomy 21
hypothyrodsim in trisomy 21Yassin Alsaleh
 
Bowen predm cme.4.9.15
Bowen predm cme.4.9.15Bowen predm cme.4.9.15
Bowen predm cme.4.9.15katejohnpunag
 
DIABETES INDUCED ERECTILE DYSFUNCTION
DIABETES INDUCED ERECTILE DYSFUNCTIONDIABETES INDUCED ERECTILE DYSFUNCTION
DIABETES INDUCED ERECTILE DYSFUNCTIONKishore Krishn
 
膀胱过度活动症的药物治疗
膀胱过度活动症的药物治疗膀胱过度活动症的药物治疗
膀胱过度活动症的药物治疗BingoMed
 
HYPER - ANDROGENISM: UPDATE OF DIAGNOSIS , Dr. Sharda Jain Dr. Jyoti Agarwal...
HYPER - ANDROGENISM:UPDATE OF DIAGNOSIS , Dr. Sharda Jain  Dr. Jyoti Agarwal...HYPER - ANDROGENISM:UPDATE OF DIAGNOSIS , Dr. Sharda Jain  Dr. Jyoti Agarwal...
HYPER - ANDROGENISM: UPDATE OF DIAGNOSIS , Dr. Sharda Jain Dr. Jyoti Agarwal...Lifecare Centre
 
2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes
2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes 2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes
2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes Jeremy F. Robles MD, FPCP, FPSEM
 
PCOS and Nutrition Thesis Defense
PCOS and Nutrition Thesis DefensePCOS and Nutrition Thesis Defense
PCOS and Nutrition Thesis DefenseWendy Thompson
 

What's hot (20)

Thyroid disorders- an overview- Dr Shahjada Selim
Thyroid disorders- an overview- Dr Shahjada SelimThyroid disorders- an overview- Dr Shahjada Selim
Thyroid disorders- an overview- Dr Shahjada Selim
 
Menopause Dr Shahjada Selim
Menopause Dr Shahjada SelimMenopause Dr Shahjada Selim
Menopause Dr Shahjada Selim
 
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
[ppt] RCpsych - Failing medical care of psychiatric patients (vMar11)
 
Family Physician's Approach to Erectile Dysfunction
Family Physician's Approach to Erectile DysfunctionFamily Physician's Approach to Erectile Dysfunction
Family Physician's Approach to Erectile Dysfunction
 
Am 8.40 diaz
Am 8.40 diazAm 8.40 diaz
Am 8.40 diaz
 
Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation Erectile dysfunction and Premature Ejaculation
Erectile dysfunction and Premature Ejaculation
 
Many Faces of Hypothyroidism, Dr. Sharda Jain
 Many Faces of Hypothyroidism, Dr. Sharda Jain  Many Faces of Hypothyroidism, Dr. Sharda Jain
Many Faces of Hypothyroidism, Dr. Sharda Jain
 
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...
Diabetes mellitus and erectile dysfunction by Dr. Mohand Yaghi PgDip (urol) C...
 
Overview of male infertility by Dr Dhahjada Selim
Overview of male infertility by Dr Dhahjada SelimOverview of male infertility by Dr Dhahjada Selim
Overview of male infertility by Dr Dhahjada Selim
 
805072 slides
805072 slides805072 slides
805072 slides
 
Erectile dysfunction in diabetes
Erectile dysfunction in diabetesErectile dysfunction in diabetes
Erectile dysfunction in diabetes
 
hypothyrodsim in trisomy 21
hypothyrodsim in trisomy 21hypothyrodsim in trisomy 21
hypothyrodsim in trisomy 21
 
Erectile Dysfunction
Erectile DysfunctionErectile Dysfunction
Erectile Dysfunction
 
Bowen predm cme.4.9.15
Bowen predm cme.4.9.15Bowen predm cme.4.9.15
Bowen predm cme.4.9.15
 
DIABETES INDUCED ERECTILE DYSFUNCTION
DIABETES INDUCED ERECTILE DYSFUNCTIONDIABETES INDUCED ERECTILE DYSFUNCTION
DIABETES INDUCED ERECTILE DYSFUNCTION
 
膀胱过度活动症的药物治疗
膀胱过度活动症的药物治疗膀胱过度活动症的药物治疗
膀胱过度活动症的药物治疗
 
What every doctor should know about pcos
What every doctor should know about pcosWhat every doctor should know about pcos
What every doctor should know about pcos
 
HYPER - ANDROGENISM: UPDATE OF DIAGNOSIS , Dr. Sharda Jain Dr. Jyoti Agarwal...
HYPER - ANDROGENISM:UPDATE OF DIAGNOSIS , Dr. Sharda Jain  Dr. Jyoti Agarwal...HYPER - ANDROGENISM:UPDATE OF DIAGNOSIS , Dr. Sharda Jain  Dr. Jyoti Agarwal...
HYPER - ANDROGENISM: UPDATE OF DIAGNOSIS , Dr. Sharda Jain Dr. Jyoti Agarwal...
 
2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes
2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes 2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes
2020-05-27 The Role of Maternal Thyroid Status on Pregnancy Outcomes
 
PCOS and Nutrition Thesis Defense
PCOS and Nutrition Thesis DefensePCOS and Nutrition Thesis Defense
PCOS and Nutrition Thesis Defense
 

Similar to Am 11.20 oxentenko

Recurrent vomiting pediatrics
Recurrent vomiting pediatricsRecurrent vomiting pediatrics
Recurrent vomiting pediatricsManoj Ghoda
 
Constipation, HHH.pptx
Constipation, HHH.pptxConstipation, HHH.pptx
Constipation, HHH.pptxHassanHabeb
 
Malabsorptive disorders final presentation
Malabsorptive disorders   final presentationMalabsorptive disorders   final presentation
Malabsorptive disorders final presentationmt53y8
 
Funtional Bowel Disease
Funtional Bowel DiseaseFuntional Bowel Disease
Funtional Bowel DiseaseMed Study
 
weight loss and constipation
weight loss and constipationweight loss and constipation
weight loss and constipationmed zar
 
An unusual cause of colic
An unusual cause of colicAn unusual cause of colic
An unusual cause of colicYasser Negm
 
Cholecystitis in Overweight Mexican American Children 08-2013
Cholecystitis in Overweight Mexican American Children 08-2013Cholecystitis in Overweight Mexican American Children 08-2013
Cholecystitis in Overweight Mexican American Children 08-2013Francisco J. Cervantes, MD, FAAP
 
My baby still appears jaundice at one month
My baby still appears jaundice at one monthMy baby still appears jaundice at one month
My baby still appears jaundice at one monthChris Cheung
 
Pancreatic_Cancer_-_Rhim.power point presentation
Pancreatic_Cancer_-_Rhim.power point presentationPancreatic_Cancer_-_Rhim.power point presentation
Pancreatic_Cancer_-_Rhim.power point presentationKelfalaHassanDawoh
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with dateMuhammad Arshad
 
Cholecystitis in overweight mexican american children 08 2013
Cholecystitis in overweight mexican american children 08 2013Cholecystitis in overweight mexican american children 08 2013
Cholecystitis in overweight mexican american children 08 2013Margarita Faz
 
Chronic Diarrhea.pptx
Chronic Diarrhea.pptxChronic Diarrhea.pptx
Chronic Diarrhea.pptxJwan AlSofi
 

Similar to Am 11.20 oxentenko (20)

Recurrent vomiting pediatrics
Recurrent vomiting pediatricsRecurrent vomiting pediatrics
Recurrent vomiting pediatrics
 
Malabsorption
Malabsorption Malabsorption
Malabsorption
 
Constipation, HHH.pptx
Constipation, HHH.pptxConstipation, HHH.pptx
Constipation, HHH.pptx
 
Malabsorptive disorders final presentation
Malabsorptive disorders   final presentationMalabsorptive disorders   final presentation
Malabsorptive disorders final presentation
 
Funtional Bowel Disease
Funtional Bowel DiseaseFuntional Bowel Disease
Funtional Bowel Disease
 
IBS
IBSIBS
IBS
 
weight loss and constipation
weight loss and constipationweight loss and constipation
weight loss and constipation
 
An unusual cause of colic
An unusual cause of colicAn unusual cause of colic
An unusual cause of colic
 
Cholecystitis in Overweight Mexican American Children 08-2013
Cholecystitis in Overweight Mexican American Children 08-2013Cholecystitis in Overweight Mexican American Children 08-2013
Cholecystitis in Overweight Mexican American Children 08-2013
 
My baby still appears jaundice at one month
My baby still appears jaundice at one monthMy baby still appears jaundice at one month
My baby still appears jaundice at one month
 
Pancreatic_Cancer_-_Rhim.power point presentation
Pancreatic_Cancer_-_Rhim.power point presentationPancreatic_Cancer_-_Rhim.power point presentation
Pancreatic_Cancer_-_Rhim.power point presentation
 
Salla disease
Salla diseaseSalla disease
Salla disease
 
Case report
Case reportCase report
Case report
 
Gastroenterology MCQs
Gastroenterology MCQsGastroenterology MCQs
Gastroenterology MCQs
 
Gallstones
GallstonesGallstones
Gallstones
 
Gastroenterology
GastroenterologyGastroenterology
Gastroenterology
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with date
 
New Kids in Town 10-2013 EDITED
New Kids in Town 10-2013 EDITEDNew Kids in Town 10-2013 EDITED
New Kids in Town 10-2013 EDITED
 
Cholecystitis in overweight mexican american children 08 2013
Cholecystitis in overweight mexican american children 08 2013Cholecystitis in overweight mexican american children 08 2013
Cholecystitis in overweight mexican american children 08 2013
 
Chronic Diarrhea.pptx
Chronic Diarrhea.pptxChronic Diarrhea.pptx
Chronic Diarrhea.pptx
 

More from plmiami

Am 8.00 workowski
Am 8.00 workowskiAm 8.00 workowski
Am 8.00 workowskiplmiami
 
Am 8.45 policar vulvovag
Am 8.45 policar vulvovagAm 8.45 policar vulvovag
Am 8.45 policar vulvovagplmiami
 
Am 9.15 awards
Am 9.15  awardsAm 9.15  awards
Am 9.15 awardsplmiami
 
Am 8.50 salganicoff
Am 8.50 salganicoffAm 8.50 salganicoff
Am 8.50 salganicoffplmiami
 
Am 8.30 lee
Am 8.30 leeAm 8.30 lee
Am 8.30 leeplmiami
 
Pm 4.45 mcintyre-seltman
Pm 4.45 mcintyre-seltmanPm 4.45 mcintyre-seltman
Pm 4.45 mcintyre-seltmanplmiami
 
Pm 4.00 wisner
Pm 4.00 wisnerPm 4.00 wisner
Pm 4.00 wisnerplmiami
 
Pm 2.45 kushner
Pm 2.45 kushnerPm 2.45 kushner
Pm 2.45 kushnerplmiami
 
Pm 1.50 trudy bush
Pm 1.50 trudy bushPm 1.50 trudy bush
Pm 1.50 trudy bushplmiami
 
Evidence based management of cardiovascular disease in women
Evidence based management of cardiovascular disease in women Evidence based management of cardiovascular disease in women
Evidence based management of cardiovascular disease in women plmiami
 
Am 11.30 grunfeld
Am 11.30 grunfeldAm 11.30 grunfeld
Am 11.30 grunfeldplmiami
 
Am 10.45 lindsay bone health
Am 10.45 lindsay bone healthAm 10.45 lindsay bone health
Am 10.45 lindsay bone healthplmiami
 
Am 9.30 robertson
Am 9.30 robertsonAm 9.30 robertson
Am 9.30 robertsonplmiami
 
Am 7.15 shulman
Am 7.15 shulmanAm 7.15 shulman
Am 7.15 shulmanplmiami
 
Pm 4.50 hochberg
Pm 4.50 hochbergPm 4.50 hochberg
Pm 4.50 hochbergplmiami
 
Pm 4.10 volfson
Pm 4.10 volfsonPm 4.10 volfson
Pm 4.10 volfsonplmiami
 
Pm 3.30 briggs
Pm 3.30 briggsPm 3.30 briggs
Pm 3.30 briggsplmiami
 
Pm 2.15 policar contracept
Pm 2.15 policar contraceptPm 2.15 policar contracept
Pm 2.15 policar contraceptplmiami
 
Pm 1.30 stefanick
Pm 1.30 stefanickPm 1.30 stefanick
Pm 1.30 stefanickplmiami
 
Pm 12.15 lindsay
Pm 12.15 lindsayPm 12.15 lindsay
Pm 12.15 lindsayplmiami
 

More from plmiami (20)

Am 8.00 workowski
Am 8.00 workowskiAm 8.00 workowski
Am 8.00 workowski
 
Am 8.45 policar vulvovag
Am 8.45 policar vulvovagAm 8.45 policar vulvovag
Am 8.45 policar vulvovag
 
Am 9.15 awards
Am 9.15  awardsAm 9.15  awards
Am 9.15 awards
 
Am 8.50 salganicoff
Am 8.50 salganicoffAm 8.50 salganicoff
Am 8.50 salganicoff
 
Am 8.30 lee
Am 8.30 leeAm 8.30 lee
Am 8.30 lee
 
Pm 4.45 mcintyre-seltman
Pm 4.45 mcintyre-seltmanPm 4.45 mcintyre-seltman
Pm 4.45 mcintyre-seltman
 
Pm 4.00 wisner
Pm 4.00 wisnerPm 4.00 wisner
Pm 4.00 wisner
 
Pm 2.45 kushner
Pm 2.45 kushnerPm 2.45 kushner
Pm 2.45 kushner
 
Pm 1.50 trudy bush
Pm 1.50 trudy bushPm 1.50 trudy bush
Pm 1.50 trudy bush
 
Evidence based management of cardiovascular disease in women
Evidence based management of cardiovascular disease in women Evidence based management of cardiovascular disease in women
Evidence based management of cardiovascular disease in women
 
Am 11.30 grunfeld
Am 11.30 grunfeldAm 11.30 grunfeld
Am 11.30 grunfeld
 
Am 10.45 lindsay bone health
Am 10.45 lindsay bone healthAm 10.45 lindsay bone health
Am 10.45 lindsay bone health
 
Am 9.30 robertson
Am 9.30 robertsonAm 9.30 robertson
Am 9.30 robertson
 
Am 7.15 shulman
Am 7.15 shulmanAm 7.15 shulman
Am 7.15 shulman
 
Pm 4.50 hochberg
Pm 4.50 hochbergPm 4.50 hochberg
Pm 4.50 hochberg
 
Pm 4.10 volfson
Pm 4.10 volfsonPm 4.10 volfson
Pm 4.10 volfson
 
Pm 3.30 briggs
Pm 3.30 briggsPm 3.30 briggs
Pm 3.30 briggs
 
Pm 2.15 policar contracept
Pm 2.15 policar contraceptPm 2.15 policar contracept
Pm 2.15 policar contracept
 
Pm 1.30 stefanick
Pm 1.30 stefanickPm 1.30 stefanick
Pm 1.30 stefanick
 
Pm 12.15 lindsay
Pm 12.15 lindsayPm 12.15 lindsay
Pm 12.15 lindsay
 

Recently uploaded

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 

Recently uploaded (20)

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 

Am 11.20 oxentenko

  • 1. GI Disorders in Women: Clinical Pearls Amy S. Oxentenko, MD, FACP, FACG Division of Gastroenterology and Hepatology Mayo Clinic, Rochester, MN March, 2012
  • 2. Disclosure of Financial Relationships Amy S. Oxentenko, MD, FACP, FACG Has no relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
  • 4. A 32 y/o female presents for evaluation of “diarrhea” and abdominal pain that she has had for 5 years. She gets lower abdominal pain and bloating 1-2 times per week. On those days, she reports 3-5 loose stools, predominantly in the morning or after meals. Stools are non-bloody, non-greasy and never nocturnal. Stooling brings relief of her pain. She denies weight loss. PMH is unremarkable. She takes no meds. She has no family hx of GI problems. Exam is normal. Which of the following is the next best step? A. No further tests; reassurance B. CBC & IgA tissue transglutaminase C. Stool cultures D. EGD w/ small bowel biopsies E. Colonoscopy w/ random biopsies
  • 5. A 32 y/o female presents for evaluation of “diarrhea” and abdominal pain that she has had for 5 years. She gets lower abdominal pain and bloating 1-2 times per week. On those days, she reports 3-5 loose stools, predominantly in the morning or after meals. Stools are non-bloody, non-greasy and never nocturnal. Stooling brings relief of her pain. She denies weight loss. PMH is unremarkable. She takes no meds. She has no family hx of GI problems. Exam is normal. Which of the following is the next best step? A. No further tests; reassurance B. CBC & IgA tissue transglutaminase C. Stool cultures D. EGD w/ small bowel biopsies E. Colonoscopy w/ random biopsies
  • 6. Be Comfortable Diagnosing IBS Spiller RC, et al. Am J Gastroenterol 2010:105;775-75. Brandt LJ, et al. Am J Gastroenterol 2009;104:S1-35.
  • 7. Irritable Bowel Syndrome Hard and lumpy Loose or watery
  • 8. Clinical Pearl Diarrhea-predominant irritable bowel syndrome is a diagnosis that can be made with little exclusionary testing required, other than a CBC and IgA tTG, in the absence of alarm symptoms.
  • 10. A 38 y/o female presents to the ER with recurrent abdominal pain, nausea and bilious vomiting. Six months ago, she had a Roux-en-Y gastric bypass for obesity. She has had 3 episodes in 1 month. Pain is crampy, periumbilical, and crescendos over 1-2 hours and is relieved after vomiting undigested food and bilious fluid. During the last 2 episodes, ER eval with labs (CBC, liver biochemistries), abdominal radiographs and RUQ ultrasounds were normal. She takes a MVI w/ iron, thiamine, calcium, vitamin D and B12, but no other meds. No other PMH. Her gallbladder was not removed w/ the laparoscopic bypass. Which of the following is the most likely cause of symptoms? A. Overeating B. Biliary colic C. Internal hernia D. Stenosis of the gastric pouch E. Medication side effect
  • 11. A 38 y/o female presents to the ER with recurrent abdominal pain, nausea and bilious vomiting. Six months ago, she had a Roux-en-Y gastric bypass for obesity. She has had 3 episodes in 1 month. Pain is crampy, periumbilical, and crescendos over 1-2 hours and is relieved after vomiting undigested food and bilious fluid. During the last 2 episodes, ER eval with labs (CBC, liver biochemistries), abdominal radiographs and RUQ ultrasounds were normal. She takes a MVI w/ iron, thiamine, calcium, vitamin D and B12, but no other meds. No other PMH. Her gallbladder was not removed w/ the laparoscopic bypass. Which of the following is the most likely cause of symptoms? A. Overeating B. Biliary colic C. Internal hernia D. Stenosis of the gastric pouch E. Medication side effect
  • 12. Gastric Gastric pouch remnant Bilio- Roux limb pancreatic limb Common channel Roux-en-Y Bypass
  • 13. ***Lesser ***Greater malabsorption malabsorption Short Roux limb Long Roux limb Long common channel Short common channel
  • 14. Early Emergent Complications • Anastomotic leaks – Early complication – Only feature may be unexplained tachycardia
  • 15. Early Emergent Complications • Anastomotic leaks – Early complication – Only feature may be unexplained tachycardia • Internal hernias – Occurs early or late – Nausea, vomiting (? bilious) – Increased w/ laparoscopy; only occurs with bypass • Both need surgery!!! Klein S, et al. Gastroenterology 2002;123:882-932.
  • 16. Other Common Complications • Marginal ulceration – May cause bleeding or stricture at G-J site – May create stomal stenosis – ? NSAIDs, ? smoking • Bleeding – Can occur at any anastomotic site – Think of remnant stomach and duodenum – After routine EGD, may need GI expertise to evaluate
  • 17. Other Common Complications • Biliary stone disease – ERCP scope 124 cm; cannot reach papilla in RYGB pts • Typical Roux limb 100-150 cm – Approach dependent on clinical acuity and local expertise papilla • Nutritional deficiencies – Iron, B12, Ca++, vitamin D – Folate (give if childbearing) – Thiamine (esp 1st 6 months)
  • 18. Clinical Pearl There are many potential structural, absorptive and nutritional complications of bariatric surgery; knowledge of the post-bariatric anatomy is essential in being able to effectively manage these patients.
  • 20. 34 y/o female referred for “IBS” who is 16 weeks pregnant. She had diarrhea in teens which resolved in her 20’s and recurred early in pregnancy. Has 4-6 BM daily with nocturnal stools. No abdominal pain. Takes a prenatal MVI, iron and levo-thyroxine. Her pre- pregnancy BMI = 17, with 5 lb weight gain thus far. Conceived her baby with IVF. Her TSH is normal. Which of the following is the next best step? A. Tissue transglutaminase IgA B. Colonoscopy C. Begin scheduled loperamide D. Stool bacterial cultures E. Begin nortriptyline
  • 21. 34 y/o female referred for “IBS” who is 16 weeks pregnant. She had diarrhea in teens which resolved in her 20’s and recurred early in pregnancy. Has 4-6 BM daily with nocturnal stools. No abdominal pain. Takes a prenatal MVI, iron and levo-thyroxine. Her pre- pregnancy BMI = 17, with 5 lb weight gain thus far. Conceived her baby with IVF. Her TSH is normal. Which of the following is the next best step? A. Tissue transglutaminase IgA B. Colonoscopy C. Begin scheduled loperamide D. Stool bacterial cultures E. Begin nortriptyline
  • 22. General and GI Manifestations of Celiac Disease General Gastrointestinal Short stature Diarrhea, steatorrhea Weight loss* Flatulence, distension Failure to thrive Abdominal discomfort Lethargy Anorexia, nausea, vomiting Delayed puberty Constipation** Edema Angular cheilosis, glossitis Rubio-Tapia A, Murray JA. * 10%+ obese Curr Opin Gastroenterol 2010; 26:116-22. ** 20% constipated
  • 23. Extraintestinal Manifestations: Celiac Disease Category Examples Hematologic Anemia (iron*, B12, folate); functional asplenia (HJ-bodies) Musculoskeletal Osteopenia/osteoporosis; osteomalacia; arthropathy Neurologic Seizures; peripheral neuropathy; ataxia Reproductive Infertility; recurrent miscarriages Skin Dermatitis herpetiformis Other Enamel defects; abnormal liver biochemistries; vitamin- deficient states, cardiomyopathy, depression/mood •*Prevalence of CD in pts with IDA: •3-9% (no GI sxs) •10-15% (GI sxs) Rubio-Tapia A, Murray JA. Curr Opin Gastroenterol 2010; 26:116-22.
  • 24. How to Diagnose Celiac Disease • TTG IgA single best screening test – IgA levels not warranted for all • Small bowel biopsies in: – All with positive serologies – Negative serology but clinical suspicion – Iron deficiency anemia – Other unexplained extraintestinal features • Treatment: Lifelong, strict gluten-free diet – Wheat, barley, rye (oats for 1st year)
  • 25. Celiac Follow-Up • Baseline: – Dietician, DEXA (latter for adults only) – CBC, folate, ferritin, B12, Ca++, zinc, copper, vit D, INR, retinol, albumin, ALT, alk phos • Follow-up visit 3-6 months: – Assess clinical sxs, serologies • Annual visits thereafter: – Assess clinical sxs, serologies, dietician – Follow-up abnormal labs; DEXA if first abnormal • Repeat biopsies ONLY for those: – Asymptomatic presentations – Persistent or recurrent sxs Leffler D. JAMA
  • 26. Clinical Pearl Celiac disease now commonly presents with “atypical” or extraintestinal features; heightened awareness of these features is key to thinking of the diagnosis.
  • 28. 28 y/o female presents with constipation for 5 years. Reports one BM every 5-7 days. She has to strain and has a sense of incomplete evacuation. She has had to digitalize on occasion to evacuate a stool. No blood. Had a significant tear with her vaginal delivery 6 years ago, requiring forceps delivery. No FHx colon cancer. Weight stable. Exam normal with the exception of paradoxical contraction of the external anal sphincter. What is the most likely diagnosis? A. Irritable bowel syndrome B. Slow-transit constipation C. Rectal prolapse D. Hirschsprung’s E. Pelvic floor dysfunction
  • 29. 28 y/o female presents with constipation for 5 years. Reports one BM every 5-7 days. She has to strain and has a sense of incomplete evacuation. She has had to digitalize on occasion to evacuate a stool. No blood. Had a significant tear with her vaginal delivery 6 years ago, requiring forceps delivery. No FHx colon cancer. Weight stable. Exam normal with the exception of paradoxical contraction of the external anal sphincter. What is the most likely diagnosis? A. Irritable bowel syndrome B. Slow-transit constipation C. Rectal prolapse D. Hirschsprung’s E. Pelvic floor dysfunction
  • 30. How to Define Constipation? • In the past: – < 3 stools per week • More recent: – Effort to defecate – Consistency and form • Bristol stool form scale • Correlates w/ transit times Brandt LJ, et al. Am J Gastroenterol 2005;100:S5-21.
  • 31. 3 Subtypes of Primary Constipation • Slow-transit constipation – Prolonged transit due to myopathy or neuropathy • Pelvic floor dysfunction – Also referred to as dyssynergic defecation – Impaired abdominal, rectoanal and pelvic floor muscle coordination • Constipation-predominant IBS – Pain or discomfort a predominant symptom; transit and pelvic function normal Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94.
  • 32. Alarm Features for Constipation? • Age > 50 years • Short duration symptoms (< 6 months) • Family hx colorectal cancer • Blood in stools • Weight loss *** These patients need an evaluation which includes colonoscopy ***
  • 33. Work-Up for Constipation • CBC, calcium, TSH, fasting glucose • If ≥ 50 or alarm features  colonoscopy • If features of pelvic floor dysfunction  a) Anorectal manometry/balloon expulsion b) Colonic transit study • 1) radio-opaque markers, or • 2) scintigraphy, or • 3) pH capsule
  • 34. Clinical Features of Pelvic Floor Dysfunction • Risk factors: childbirth, abuse, chronic constipation, other pelvic trauma • Excessive straining, toilet rocking or repositioning • Sense of incomplete evacuation • Sense of anorectal blockage* • Digitation for stool evacuation* Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94.
  • 35. Examination Features of Pelvic Floor Dysfunction • Abnormal perineal descent • Abnormal resting and squeeze tone • Paradoxical contraction of puborectalis or external anal sphincter Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94.
  • 36. Pelvic Floor Dysfunction Normal Rest Normal defecation Those with pelvic floor dysfunction have paradoxical contraction of puborectalis and external sphincter
  • 37. Management of Pelvic Floor Dysfunction • Refer for biofeedback program • Significantly improves (for at least 1 year): • Spontaneous BMs • Dyssynergia • Balloon expulsion time • Colonic transit time • If there is concomitant prolapse, fix pelvic floor dysfunction first Bharucha AE, Wald AM. Am J Gastroenterol 2010;105;786-94. Rao SSC, et al. Am J Gastroenterol 2010;105:890-6.
  • 38. Clinical Pearl Constipation associated with a sense of anorectal blockage, the need for digitation to evacuate stool, and paradoxical contraction of the puborectalis is suggestive of pelvic floor dysfunction; anorectal manometry is indicated.
  • 40. A 58 year old female presents for an evaluation of diarrhea that has been present for 4 months. She has crampy pain, bloating and weight loss of 10 pounds. She denies any blood in her stool, but notes it to be foul smelling and greasy appearing. No recent medication changes. No travel. She does have a history of prior cervical cancer 4 years ago, s/p resection, chemotherapy and radiation. Labs reveal a hemoglobin of 10.4 g/dL, MCV of 102 fL and albumin of 3.1 g/dL. She states that dairy avoidance has somewhat, but not fully, helped. TTG IgA is normal. Colonoscopy with ileal inspection is normal. Which of the following is the next best step? A. CT of the pancreas B. Lactose breath test C. PET scan D. Lactulose breath test E. Flex sig w/ biopsies
  • 41. A 58 year old female presents for an evaluation of diarrhea that has been present for 4 months. She has crampy pain, bloating and weight loss of 10 pounds. She denies any blood in her stool, but notes it to be foul smelling and greasy appearing. No recent medication changes. No travel. She does have a history of prior cervical cancer 4 years ago, s/p resection, chemotherapy and radiation. Labs reveal a hemoglobin of 10.4 g/dL, MCV of 102 fL and albumin of 3.1 g/dL. She states that dairy avoidance has somewhat, but not fully, helped. TTG IgA is normal. Colonoscopy with ileal inspection is normal. Which of the following is the next best step? A. CT of the pancreas B. Lactose breath test C. PET scan D. Lactulose breath test E. Flex sig w/ biopsies
  • 42. ©2011 MFMER | 3149421-42
  • 43. Causes of Bacterial Overgrowth Small bowel diverticula Structural Small bowel strictures (radiation, IBD, NSAIDs) Enterocolonic fistula Blind loops, afferent limbs Surgical Ileocecal valve resection Chronic pseudoobstruction (Scleroderma) Dysmotility Amyloidosis Diabetic neuropathy Achlorhydria/atrophy Diminished Gastric resection Acid Acid suppression Chronic liver or kidney disease Other Chronic pancreatitis Immunodeficiencies Celiac disease Elderly (15% prevalence)
  • 44. Diagnosis of SIBO • Small bowel cultures – Anaerobic & aerobic; > 105 organisms/mL – Jejunum; most taken from duodenum • Hydrogen breath testing – Lactulose (rise by 20 ppm first 90 min) – Glucose (rise by 12 ppm first 90 min) – 2nd criteria = double peak (small bowel, colon) – False (+): rapid transit, recent food – False (-): methane producer (10%), antibiotics • Empiric Trial of Antibiotics
  • 45. Breath Testing SIBO A B C A) Lactulose breath test without SIBO B) Lactulose breath test w/ SIBO C) Lactulose breath test w/ SIBO & double-peak pattern From Dukowicz AC, et al. Gastroenterol Hepatol 2007;3:118-119. ©2011 MFMER | 3149421-45
  • 46. Treatment of SIBO • Modify underlying risk factor (minority) – Diabetes, surgery, etc. • Nutritional support – Correct deficiencies (vit B12, vit D, Ca++) – Lactose malabsorption (secondary) • Antibiotic therapy – Single 7-10 days (46-90% improve for months) – Recurrence 44% at 9 months – Some may need repeat courses (1 week/month)
  • 47. Treatment for Bacterial Overgrowth Ciprofloxacin 250 mg BID Norfloxacin 800 mg QD Metronidazole 250 mg TID Trimethoprim-SMX 1 DS BID Doxycycline 100 mg BID Tetracycline 250 mg QID Amoxicillin-clavulanate 500 mg TID Rifaximin 800-1200 mg QD Quigley EMM, et al. Infect Dis Clin N Am 2010; 24: 943-59.
  • 48. Clinical Pearl Small intestinal bacterial overgrowth is typically diagnosed with small bowel cultures or hydrogen breath testing; management includes correcting nutritional abnormalities and antibiotic therapy. ©2011 MFMER | 3149421-48